Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:32 AM
Ignite Modification Date:
2025-12-25 @ 2:32 AM
NCT ID:
NCT03234634
Eligibility Criteria:
Inclusion Criteria:
* Acute ischemic stroke
* Age ≥ 19 years old
* Modified Rankin Scale score before qualifying stroke, 0 or 1
* Baseline National Institute of Health Stroke Scale, 5 or greater
* Baseline Alberta Stroke Program Early Computed Tomographic Sign, 6 or greater
* Documented occlusion of relevant intracranial internal carotid artery or middle cerebral artery M1 segment on multiphase CT angiogram
* Starting of endovascular treatment (femoral artery puncture) should be possible between 150 minutes and 600 minutes after last seen well time.
* Nonenhanced CT and multiphase CT angiogram should be obtained in the participating hospital
* If indicated, intravenous administration of tissue plasminogen activator should be given.
Exclusion Criteria:
* Femoral puncture is impossible
* Pregnancy or positive on serum beta-hCG test
* Known uncontrollable allergic reaction to iodized contrast media
* Intracranial cerebral artery dissection
* Suspected chronic occlusion of the relevant intracranial large artery
* In hospital stroke
* Bilateral internal carotid artery or middle cerebral artery occlusion
* Underlying severe medical or surgical disease which may affect treatment response.
* Clinical follow is impossible because of social or medical problems.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Study:
NCT03234634
Study Brief:
Protocol Section:
NCT03234634